Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance.

AR, Chugh; GM, Beache; JH, Loughran; N, Mewton; JB, Elmore; J, Kajstura; P, Pappas; A, Tatooles; MF, Stoddard; JA, Lima; MS, Slaughter; P, Anversa; R, Bolli

doi:10.1161/circulationaha.112.092627

Public

Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance.

Shared by NobleBlocks on Sep 1, 2012 • 12:00 AM UTC

Authors:

Chugh AR

Beache GM

Loughran JH

Abstract

Background SCIPIO is a first-in-human, phase 1, randomized, open-label trial of autologous c-kit(+) cardiac stem cells (CSCs) in patients with heart failure of ischemic etiology undergoing coronary artery bypass grafting (CABG). In the present study, we report the surgical aspects and interim cardia...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!